HepatologyVolume 7, Issue 3 p. 617-618 CorrespondenceFree Access Correspondence Sergio Gammal, Sergio Gammal Liver Diseases Section, Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this authorDavid Geller, David Geller Liver Diseases Section, Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this author Sergio Gammal, Sergio Gammal Liver Diseases Section, Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this authorDavid Geller, David Geller Liver Diseases Section, Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this author First published: May/June 1987 https://doi.org/10.1002/hep.1840070352AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Rzepczynski D, Zieve L, Lindblad S, et al. In vivo studies of GABAergic effects in experimental hepatic encephalopathy. Hepatology 1986; 6: 902– 905. 2 Baraldi M, Zeneroli ML, Ventura E, et al. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci 1984; 67: 167– 175. 3 Bassett ML, Mullen KD, Skolnick P, et al. GABA and benzodiazepine antagonists ameliorate hepatic encephalopathy in a rabbit model of hepatic failure (Abstract). Hepatology 1985; 5: 1032. 4 Scollo-Lavizzari G, Steinmann E. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1985; 1: 1324– 1325. 5 Bansky G, Meier PJ, Ziefler WH, et al. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15–1788). Lancet 1985; 1: 1324– 1325. 6 Ferenci P, Zieve L, Ebner J, et al. Postsynaptic neural membrane affinity for GABA and receptor density are unaltered in hepatic coma following portacaval shunt (PCS) and hepatic artery ligation (HAL) (Abstract). Hepatology 1986; 6: 1143. Volume7, Issue3May/June 1987Pages 617-618 ReferencesRelatedInformation